Clinical Trial Update: Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enobosarm in combination with abemaciclib for ER+HER2- metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Enobosarm (enobosarm)

Snippet

Sponsor: Veru Inc. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: TERMINATED